Medicine Journal Impact Factor Ranking

Medicine Journal Impact Factor Ranking Apr 10 2025 nbsp 0183 32 The National Academy of Medicine convened a workshop of experts and published a report that reviews the progress generative AI has achieved in health care and discusses

Jun 22 2025 nbsp 0183 32 Semaglutide at a dose of 2 4 mg has established weight loss and cardiovascular benefits and cagrilintide at a dose of 2 4 mg has shown promising results in early phase trials May 11 2025 nbsp 0183 32 Tirzepatide and semaglutide are highly effective medications for obesity management The efficacy and safety of tirzepatide as compared with semaglutide in adults

Mar 1 2025 nbsp 0183 32 Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe uncontrolled asthma and a history of chronic rhinosinusitis with nasal polyps but

Pre-crafted templates offer a time-saving option for creating a varied range of files and files. These pre-designed formats and designs can be utilized for numerous personal and professional jobs, including resumes, invitations, leaflets, newsletters, reports, discussions, and more, streamlining the content production process.

Medicine Journal Impact Factor Ranking

Journal Impact Factor 2024 Loria Nichol

Abs 2025 Journal Ranking 2025 Addia Anselma

Medical Journal Impact Factor 2019 List

Biorxiv Impact Factor 2021

Journal Of Diabetes Impact Factor 2025 Noel L Jackson

2022 Nature

Nonoperative Management Of Mismatch Repair Deficient Tumors

https://www.nejm.org › doi › full
Apr 27 2025 nbsp 0183 32 Among patients with mismatch repair deficient dMMR locally advanced rectal cancer neoadjuvant checkpoint blockade eliminated the need for surgery in a high proportion

Overall Survival With Neoadjuvant Nivolumab Plus Chemotherapy

https://www.nejm.org › doi › full
Jun 2 2025 nbsp 0183 32 Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event free survival in patients with resectable non small cell lung

Tolebrutinib In Nonrelapsing Secondary Progressive Multiple

https://www.nejm.org › doi › full
Apr 8 2025 nbsp 0183 32 Throughout the course of multiple sclerosis gradually progressive neurologic impairment can occur which has been called disability accrual Current disease modifying

Survival Of Transplanted Allogeneic Beta Cells With No

https://www.nejm.org › doi › full
Aug 4 2025 nbsp 0183 32 The need to suppress a patient s immune system after the transplantation of allogeneic cells is associated with wide ranging side effects We report the outcomes of

The Spectrum Of Fragile X Disorders The New England Journal Of

https://www.nejm.org › doi › full
Jul 16 2025 nbsp 0183 32 Fragile X disorders include two distinct conditions fragile X syndrome the most common single gene cause of developmental delay and autism and an entirely separate

[desc-11] [desc-12]

[desc-13]